View navigation
CuPiD is a 3-year EU project to provide personalised rehabilitation via telemedicine for the major motor impairments caused by Parkinson’s disease.
Parkinson’s disease is a neurodegenerative disorder of unknown cause that affects areas of the brain necessary for movement control. Recent research confirms the value of motor learning in Parkinson’s and shows that lasting improvements can be achieved through training.
CuPiD will develop innovative rehabilitation services based on the principles of motor learning and using telemedicine technology to allow the services to be delivered to the home with remote monitoring by clinicians.
This project continues OCC’s long involvement in Parkinson’s disease research, including the PERFORM project and the development of virtual reality glasses.
CuPiD will develop and test three new ‘closed-loop’ telemedicine services:
This is the first time that such diverse and comprehensive training in a home setting has been proposed for patients with Parkinson’s disease. The outcome of the CuPiD project will establish the feasibility and long-term efficacy of this form of rehabilitation and enhance the field of non-pharmaceutical intervention.
Case Studies
In response to certain visual cues, some Parkinson’s disease patients experience ‘kinesia paradoxa’ – a sudden disappearance of the major symptoms, greatly increased mobility and a subjective feeling of well-being.
Case Studies
AiSentia emerged as a spin-out company from an industry-leading research project at the University of Oxford. Their aim was simple: to alleviate the need for patients undergoing a CT scan to be given an injection of radiological contrast media (RCM). Instead, AiSentia have created a generative AI model that processes CT X-Ray images and enhances them by raising the contrast of the CT images. This improves the visibility of relevant issues within the human body and eliminates the need for RCM.
